A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, ...

An experimental monoclonal antibody called ianalumab had promising results for more than half of patients with primary immune thrombocytopenia enrolled in a phase 3 trial, according to data published ...

The researchers argue that their findings, published in Scientific Reports, could help clinicians anticipate which patients ...

A small group of patients with an otherwise incurable form of T‑ cell leukaemia have seen their cancer driven into remission ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best pharma stocks to invest in. Cantor Fitzgerald analyst Carter Gould ...

A quick revision guide covering key concepts, biomolecules, cell organelles, and essential NEET-style MCQs to boost exam ...

This comprehensive review examines vitamin B12 absorption, physiological roles, deficiency states, and dietary sources, with ...

Vera Therapeutics, Inc. ('Vera Therapeutics”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and ...

In a new trial, the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease progression and was well tolerated with a more favorable safety profile when ...

At Stillwater, corrections officials are testing an “earned living unit” that trades privileges for accountability and has gone two months without a lockdown.